Although CCL20 is known to induce ERK1/2 signaling in lung cancer cells 43, we did not observed the attenuation of ERK1/2 signaling following knockdown of CCL20 in PC cell lines, suggesting that CCL20 signaling might activate differential downstream signaling dependent in specific cancer types. This evidence concerns the gene MAPK3 and cancer.